Combined treatment method for type 2 diabetes by using camel milk and rosiglitazone maleate

Combined treatment method for type 2 diabetes by using camel milk and rosiglitazone maleate

  • CN 101,015,566 A
  • Filed: 03/13/2007
  • Published: 08/15/2007
  • Est. Priority Date: 03/13/2007
  • Status: Active Application
First Claim
Patent Images

1. , with bactrian camel milk and rosiglitazone maleate therapeutic alliance type ii diabetes, it is characterized by animal experiment active drug composition is rosiglitazone maleate 1-3mg/kg body weight, bactrian camel milk 1-6ml, it is rosiglitazone maleate 4mg that human clinical trial'"'"'s active drug is formed, bactrian camel milk 8ml during preparation joins rosiglitazone maleate and forms suspension in the bactrian camel milk.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×